Welcome to CDC stacks | Urine tenofovir and emtricitabine concentrations provide biomarker for exposure to HIV preexposure prophylaxis - 47327 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Urine tenofovir and emtricitabine concentrations provide biomarker for exposure to HIV preexposure prophylaxis
  • Published Date:
    Jul 17 2017
  • Source:
    AIDS. 31(11):1647-1650.
  • Language:
    English
Filetype[PDF-407.10 KB]


Details:
No Related Documents.
You May Also Like:
  1. Levels of intracellular phosphorylated tenofovir and emtricitabine correlate with natural substrate concentrations in peripheral blood mononuclear cells of persons prescribed daily oral Truvada™ for HIV pre-exposure prophylaxis
    Personal Author:
    Haaland, Richard E.; Holder, Angela; Pau, Chou-Pong; Swaims-Kohlmeier, Alison; Dawson, Carolyn; Smith, Dawn K.; Segolodi, Tebogo M.; Thigpen, Michael C.; Paxton, Lynn A.; Parsons, Teresa L.; Hendrix, Craig W.; Hart, Clyde E.;
    Published:
    Jul 01 2017
    Source:
    J Acquir Immune Defic Syndr. 75(3):e86-e88.
    File Type:
    Filetype[PDF - 389.37 KB]
  2. Preexposure prophylaxis for the prevention of HIV infection in the United States – 2017 update : a clinical practice guideline
    Corporate Author:
    United States. Public Health Service.. Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention. Preexposure Prophylaxis Work Group..
    Published:
    March 2018
    Description:
    The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014 was published in an electronic format in July 2014 so that it could be updated as relevant changes in supporting evidence became available. The Preexposure ...
    Status:
    current
    File Type:
    Filetype[PDF - 1.67 MB]
  3. Preexposure prophylaxis for the prevention of HIV infection – 2014 : clinical providers’ supplement
    Personal Author:
    Smith, Dawn K.; Koenig, Linda J.; Martin, Michael; Mansergh, Gordon; Heneine, Walid; Ethridge, Steven F.; Morgan, Marie S.; Mermin, Jonathan; Fenton, Kevin A.;
    Corporate Author:
    United States. Public Health Service.. Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.).
    Published:
    May 14, 2014
    Description:
    For the Clinical Practice Guideline that serves as the basis for this Clinical Providers’ Supplement, see Preexposure prophylaxis for the prevention of HIV infection – 2014 : a clinical practice guideline....
    Status:
    superseded
    File Type:
    Filetype[PDF - 690.62 KB]
  4. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults
    Personal Author:
    Smith, Dawn K.; Thigpen, Michael C.; Nesheim, Steven R.; Lampe, Margaret A.; Paxton, Lynn A.; Samandari, Taraz; Lansky, Amy; Mermin, Jonathan; Fenton, Kevin A.;
    Corporate Author:
    Substance Abuse and Mental Health Services Administration (U.S.)
    Published:
    Aug 10 2012
    Source:
    MMWR Morb Mortal Wkly Rep. 2012 Aug 10;61(31):586-9.
    Description:
    Morbidity and mortality weekly report. 2012 Aug 10;61(31):586-9. : In the United States, an estimated 48,100 new human immunodeficiency virus (HIV) infections occurred in 2009. Of these, 27% were in heterosexual men and women who did not inject drugs...
    File Type:
    Filetype[PDF - 96.99 KB]
  5. Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men1
    Personal Author:
    Hoenigl, Martin; Jain, Sonia; Moore, David; Collins, Deborah; Sun, Xiaoying; Anderson, Peter L.; Corado, Katya; Blumenthal, Jill S.; Daar, Eric S.; Milam, Joel; Dubé, Michael P.; Morris, Sheldon;
    Corporate Author:
    for the California Collaborative Treatment Group 595 Team
    Published:
    December 2018
    Source:
    Emerg Infect Dis. 24(12):2292-2302
    Description:
    The effectiveness of oral HIV preexposure prophylaxis (PrEP) strongly depends on maintaining adherence. We investigated the association between substance use and PrEP adherence, as well as incident sexually transmitted infections (STIs) in a high-ris...
    File Type:
    Filetype[PDF - 1.35 MB]